New tentative approval for Eugia Pharma drug palbociclib
July 22, 2022 Comments Off on New tentative approval for Eugia Pharma drug palbociclib Posted in: Tentative Approval Palbociclib is the generic ingredient in one branded drug marketed by Pfizer and is included in two NDAs. There are six patents protecting this compound. Drug patent litigation for PALBOCICLIB.…
The post New tentative approval for Eugia Pharma drug palbociclib appeared first on DrugPatentWatch - Make Better Decisions.
Comments are closed.
New tentative approval for Eugia Pharma drug palbociclib
Comments Off on New tentative approval for Eugia Pharma drug palbociclib Posted in: Tentative Approval Palbociclib is the generic ingredient in one branded drug marketed by Pfizer and is included in two NDAs. There are six patents protecting this compound. Drug patent litigation for PALBOCICLIB.…
The post New tentative approval for Eugia Pharma drug palbociclib appeared first on DrugPatentWatch - Make Better Decisions.
Comments are closed.